在急性心力衰竭中当前的药理学和非药理学解压策略 - - 证据和实用指导
Lara E E C Zonneveld1, Kevin Damman1, Maria Rosa Costanzo2
1University of Groningen, Department of Cardiology, University Medical Center Groningen, University of Groningen, The Netherlands.
Journal of cardiac failure
|December 12, 2025
概括
治疗急性不补偿性心力衰竭 (ADHF) 需要改进,而不仅仅是循环利尿剂. 量身定制的,针对患者的具体方法显示出更好的脱和ADHF治疗结果的希望.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 临床医学 临床医学
背景情况:
- 急性不补偿性心力衰竭 (ADHF) 是住院的主要原因.
- 目前的管理通常依赖于循环利尿剂,这可能导致不充分的脱血和重入医院.
- 需要优化药理学策略来改善患者的治疗结果.
研究的目的:
- 审查ADHF目前的治疗场景.
- 分析ADHF管理的最新进展和临床试验.
- 提供针对ADHF量身定制的,针对患者的治疗策略的新见解.
主要方法:
- 关于ADHF管理的最新发展的文献综述.
- 对临床试验的分析,重点是降血策略.
- 综合信息,提出一个量身定制的治疗方法.
主要成果:
- 单独使用循环利尿剂往往不足以有效地减少ADHF的堵塞.
- 根据患者个体因素量身定制降血策略是一种有前途的方法.
- 最近的研究强调了个性化医学的重要性在管理ADHF.
结论:
- 优化ADHF的药理管理对于减少住院治疗至关重要.
- 一种定制的方法,优先考虑患者特异性因素,可以提高治疗疗效.
- 本综述为管理ADHF的临床医生提供了实际指导.
更多相关视频
相关概念视频
Heart Failure V: Medical Management
198
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
198
Heart Failure VI: Adjunct Therapies
235
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
235
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
879
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
879
Upper Respiratory Drugs: Decongestants
773
Decongestants are a class of medications used primarily to alleviate nasal congestion, a common symptom resulting from allergies, colds, sinusitis, and other upper respiratory tract infections. These drugs work by activating α-adrenergic receptors, constricting small blood vessels in the nasal membranes. This action results in the opening of clogged nasal passages, thereby facilitating sinus drainage and relieving congestion.
Most decongestants are readily available over-the-counter in...
Most decongestants are readily available over-the-counter in...
773
Heart Failure Drugs: Diuretics
764
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
764
Heart Failure VII: Nursing Interventions
396
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
396


